VIKING GLOBAL INVESTORS LP Insider Trading $ADPT Adaptive Biotechnologies Corp
Get free email notifications about insider trading for VIKING GLOBAL INVESTORS LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL INVESTORS LP. VIKING GLOBAL INVESTORS LP is 10% Owner in FIRST DATA CORP ($FDC) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and 10% Owner in Wayfair Inc. ($W) and 10% Owner in Axovant Sciences Ltd. ($AXON) and 10% Owner in 4D Molecular Therapeutics Inc. ($FDMT) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and 10% Owner in Zentalis Pharmaceuticals, Inc. ($ZNTL) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and 10% Owner in Urovant Sciences Ltd. ($UROV).
VIKING GLOBAL INVESTORS LP in Adaptive Biotechnologies Corp
Trading Symbol: ADPTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL INVESTORS LP: 10% Owner
Holdings: 29,993,708 shares
Latest Transaction: Dec 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of VIKING GLOBAL INVESTORS LP in Adaptive Biotechnologies Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDMT, ADPT, TKMR, BBIO, EDIT, FDC, INBX, MYOV, AXON, UROV, W, ZNTL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 55.65 | 1,000,000 | 55,650,000 | 29,993,708 | 31 M to 30 M (-3.23 %) |
Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |
Jan 30 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Sell | S | 24.98 | 4,912,899 | 122,706,039 | 33,493,708 | 38.4 M to 33.5 M (-12.79 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 290,572 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,007,740 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 15,524,350 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 18,908,945 | 0 | 0 | |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 290,572 | 0 | 38,406,607 | 38.1 M to 38.4 M (+0.76 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 2,007,740 | 0 | 38,116,035 | 36.1 M to 38.1 M (+5.56 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 15,524,350 | 0 | 36,108,295 | 20.6 M to 36.1 M (+75.42 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 18,908,945 | 0 | 20,583,945 | 1.7 M to 20.6 M (+1,128.89 %) |
Jul 02 2019 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 20.00 | 250,000 | 5,000,000 | 1,675,000 | 1.4 M to 1.7 M (+17.54 %) |
Page: 1